A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors
| Image |  |
|---|---|
| Description | scientific article published on 3 April 2018 |
| Author/s |
author: Carol Aghajanian Lillian Siu |
| Publication date | April 3, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |